Diagnostic Values of Venous Peak Lactate, Lactate-to-pyruvate Ratio, and fold Increase in Lactate from Baseline in Aerobic Exercise Tests in Patients with Mitochondrial Diseases-Reference-Cited by-同舟云学术

Diagnostic Values of Venous Peak Lactate, Lactate-to-pyruvate Ratio, and fold Increase in Lactate from Baseline in Aerobic Exercise Tests in Patients with Mitochondrial Diseases

Published:2022 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kurihara Masanori¹,Sugiyama Yusuke¹,Tanaka Masaki¹,Sato Kenichiro¹,Mitsutake Akihiko¹,Ishiura Hiroyuki¹,Kubota Akatsuki¹,Sakuishi Kaori¹,Hayashi Toshihiro¹,Iwata Atsushi¹,Shimizu Jun¹,Murayama Kei²,Tsuji Shoji³,Toda Tatsushi¹

Affiliation:

1. Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan

2. Department of Metabolism, Chiba Children's Hospital, Japan

3. Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8629-21/_pdf

Reference38 articles.

1. 1. Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet. Med 17 (9): 689-701, 2015.

2. 2. Liang C, Ahmad K, Sue CM. The broadening spectrum of mitochondrial disease: shifts in the diagnostic paradigm. Biochim. Biophys. Acta 1840 (4): 1360-1367, 2014.

3. 3. Suomalainen A, Elo JM, Pietiläinen KH, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet. Neurol 10 (9): 806-818, 2011.

4. 4. Davis RL, Liang C, Edema-Hildebrand F, Riley C, Needham M, Sue CM. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology 81 (21): 1819-1826, 2013.

5. 5. Yatsuga S, Fujita Y, Ishii A, et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann. Neurol 78 (5): 814-823, 2015.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications;Frontiers in Psychiatry;2024-01-05

2. Biomarkers of Redox Balance Adjusted to Exercise Intensity as a Useful Tool to Identify Patients at Risk of Muscle Disease through Exercise Test;Nutrients;2022-04-29